Form 4 for OM Outset Medical, Inc.
Accepted 2021-10-19 00:00:00 ET · period of report 2021-10-15 · accession 0001484612-21-000070 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-19 | 2021-10-15+ | OM | Brottem John L. | GC | S - Sale+OE | $49.31 | -4,945 | 15.0K | -25% | -$243.8K |
| DM | 2021-10-19 | 2021-10-15+ | OM | Brottem John L. | GC | M - OptEx | $9.48 | +4,945 | 16.5K | +43% | +$46.9K |
| DM | 2021-10-19 | 2021-10-15+ | OM | Brottem John L. | GC | M - OptEx | $0.00 | -4,945 | 17.3K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-15 | S | D | 3,500 | $49.02 | 15,047 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $48.60 to $49.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2021-10-15 | M | A | 3,500 | $9.48 | 18,547 | D | — | — | |
| 3 | Common | Common Stock | 2021-10-19 | S | D | 1,445 | $50.00 | 15,047 | D | — | — | |
| 4 | Common | Common Stock | 2021-10-19 | M | A | 1,445 | $9.48 | 16,492 | D | — | — | |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-10-19 | M | D | 1,445 | $0.00 | 60,673 | D | $9.48 · — to 2030-05-26 | 1,445 Common Stock | (F3) This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. |
| 6 | Derivative | Performance Options (right to buy) | 2021-10-15 | M | D | 3,500 | $0.00 | 17,265 | D | $9.48 · — to 2030-05-26 | 3,500 Common Stock | (F4) This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event. |